Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope?
Open accessAbstract
Abstract: Despite the fact that nonmotor symptoms (NMS) like gastrointestinal (GI) complaints are frequently reported in Parkinson’s disease (PD), no therapeutic guidelines are available. This study aimed to manage some lower GI-NMS in a group of patients with PD. A total of 40 patients (17 males, 23 females; mean age 76.05±2.09 years) were randomly selected for this study. Patients were confirmed to have PD (modified Hoehn–Yars scale: 2.075±0.4) who had undergone levodopa or dopamine agonist treatment. In the non-motor symptoms questionnaire (NMS-Quest), regarding GI complaints, the following were recorded: abdominal pain, bloating, and constipation of mild-to-moderate severity. Laboratory studies, abdominal ultrasound, and upper and lower digestive endoscopies were performed to rule out organic issues. All patients increased their water intake to 2 L/d and alimentary fiber to 20–25 g/d. Twenty patients received trimebutine 200 mg three times daily half an hour before meals. The other 20 patients received probiotics (60 mg per-tablet of two lactic bacteria: Lactobacillus acidophilus and Bifidobacterium infantis ), 2×/d, 1 hour after meals for 3 months along with the reassessment of GI complaints. Our results demonstrated that there were significant statistical differences in all assessed symptoms in the first group: 1.55±0.51 vs 0.6±0.5 ( P <0.0001) for abdominal pain; 1.6±0.5 vs 0.45±0.51 ( P <0.0001) for bloating; and 1.5±0.51 vs 0.85±0.67 ( P =0.0014) for constipation with incomplete defecation. The second group displayed statistical differences only for abdominal pain 1.45±0.51 vs 1.05±0.69 ( P =0.00432) and bloating 1.4±0.5 vs 0.3±0.47 ( P <0.0001). For constipation with incomplete defecation, there was a slight improvement. Thus, there was no significant statistical difference: 1.35±0.49 vs 1.15±0.49 ( P =0.2040). In conclusion, lower GI-NMS are frequently present, isolated or associated with other autonomic issues, even before the diagnosis of PD. Treatment with probiotics could improve abdominal pain and bloating as much as with trimebutine, but less for constipation with incomplete evacuation, where trimebutine showed better results. Keywords: PD, lower GI-NMS, probiotics, prokinetics, trimebutine
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies have shown that Lactobacillus acidophilus and Bifidobacterium infantis can improve abdominal pain and bloating in PD patients.
“studies have shown that Lactobacillus acidophilus and Bifidobacterium infantis can improve abdominal pain and bloating in PD patients [40]”
From Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota (2021) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807 · see citing works
Goetz, C. G., Poewe, W. H., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C. E., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,360 · see citing works
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968 · see citing works
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, К. R., & Schapira, A. H. V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,739 · see citing works
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445 · see citing works
What contributes to quality of life in patients with Parkinson's disease?
Schrag, A. E. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,380 · see citing works
Frequency of Bowel Movements and the Future Risk of Parkinson’s Disease
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., Grandinetti, A., Blanchette, P. L., Popper, J. S., & Ross, G. W. (2001) · Neurology · doi:10.1212/wnl.57.3.456 · Cited by 839 · see citing works
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583 · see citing works
Martínez‐Martín, P., Schapira, A. H. V., Stocchi, F., Sethi, K. D., Odin, P., Macphee, G. J. A., Brown, R. G., Naidu, Y., Clayton, L. M. S., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 556 · see citing works
Cersosimo, M. G., Raina, G. B., Pecci, C., Pellene, A., Calandra, C. R., Gutiérrez, C., Micheli, F. E., & Benarroch, E. E. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6801-2 · Cited by 314 · see citing works
Domperidone: A Peripherally Acting Dopamine 2 -Receptor Antagonist
Barone, J. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18003 · Cited by 260 · see citing works
Antonini, A., Barone, P., Marconi, R., Morgante, L., Zappulla, S., Pontieri, F. E., Ramat, S., Ceravolo, M. G., Meco, G., Cicarelli, G., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6557-8 · Cited by 238 · see citing works
Nonmotor manifestations of Parkinson's disease
Simuni, T., & Sethi, K. D. (2009) · Annals of Neurology · doi:10.1002/ana.21472 · Cited by 236 · see citing works
The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism
Pressley, J. C., Louis, E. D., Tang, M. ‐., Cote, L. J., Cohen, P. D., Glied, S., & Mayeux, R. P. (2003) · Neurology · doi:10.1212/wnl.60.1.87 · Cited by 229 · see citing works
Symptoms of autonomic failure in Parkinson?s disease: prevalence and impact on daily life
Magerkurth, C., Schnitzer, R., & Braune, S. (2005) · Clinical Autonomic Research · doi:10.1007/s10286-005-0253-z · Cited by 215 · see citing works
(2011) · PubMed · Cited by 207 · see citing works
Neural control of the gastrointestinal tract: Implications for Parkinson disease
Cersosimo, M. G., & Benarroch, E. E. (2008) · Movement Disorders · doi:10.1002/mds.22051 · Cited by 188 · see citing works
Zangaglia, R., Martignoni, E., Glorioso, M., Ossola, M., Riboldazzi, G., Calandrella, D., Brunetti, G., & Pacchetti, C. (2007) · Movement Disorders · doi:10.1002/mds.21243 · Cited by 177 · see citing works
The nonmotor symptoms of Parkinson's disease—An overview
Lim, S., & Lang, A. E. (2010) · Movement Disorders · doi:10.1002/mds.22786 · Cited by 171 · see citing works
WANG, A., LIAO, X., XIONG, L., PENG, S., XIAO, Y., LIU, S., HU, P., & CHEN, M. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-43 · Cited by 143 · see citing works
Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology
Asahina, M., Vichayanrat, E., Low, D. A., Iodice, V., & Mathias, C. J. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303135 · Cited by 139 · see citing works
Meta‐analysis of the effects of prokinetic agents in patients with functional dyspepsia
Hiyama, T., Yoshihara, M., Matsuo, K., Kusunoki, H., Kamada, T., Ito, M., Tanaka, S., Nishi, N., Chayama, K., & Haruma, K. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04493.x · Cited by 109 · see citing works
Non-motor symptoms of Parkinson’s disease: the patient’s perspective
Breen, K. C., & Drutyte, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0928-2 · Cited by 74 · see citing works
Schmulson, M., & Chang, L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04637.x · Cited by 70 · see citing works
The impact and management of nonmotor symptoms of Parkinson's disease.
Lyons, K. E., & Pahwa, R. (2011) · PubMed · Cited by 51 · see citing works
Non-Motor Aspects of Parkinson's Disease
Borek, L. L., Amick, M. M., & Friedman, J. H. (2006) · CNS Spectrums · doi:10.1017/s1092852900013560 · Cited by 51 · see citing works
What contributes to quality of life in patients with Parkinson's disease?
Ward, C. D. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.289a · Cited by 39 · see citing works
[Autonomic disorders in Parkinson's disease].
Gołąb-Janowska, M., Budzianowska, A., & Honczarenko, K. (2011) · PubMed · Cited by 15 · see citing works
Gastrointestinal Symptoms in Parkinson Disease: Clinical Aspects and Management
Salat-Foix, D., Andrews, C. N., Meddings, J. B., & Suchowersky, O. (2011) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012099 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 562 · see citing works
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., Barba, C. D., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 422 · see citing works
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A. S., & Covașă, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 316 · see citing works
Shandilya, S., Kumar, S., Jha, N. K., Kesari, K. K., & Ruokolainen, J. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.09.005 · Cited by 300 · see citing works
Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders
Cheng, L.-H., Liu, Y.-W., Wu, C.-C., Wang, S. Z., & Tsai, Y.-C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2019.01.002 · Cited by 292 · see citing works
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M. J., Shukla, A. W., Ramirez‐Zamora, A., Mai, V., & Vedam‐Mai, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.782082 · Cited by 191 · see citing works
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177 · see citing works
Ibrahim, A., Ali, R. A. R., Manaf, M. R. A., Ahmad, N., Tajurruddin, F. W., Qin, W. Z., Desa, S. H. M., & Ibrahim, N. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244680 · Cited by 173 · see citing works
Hsieh, T.-H., Kuo, C.-W., Hsieh, K.-H., Shieh, M.-J., Peng, C.-W., Chen, Y.-C., Chang, Y.-L., Huang, Y.-Z., Chen, C.-C., Chang, P.-K., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10040206 · Cited by 174 · see citing works
Probiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 152 · see citing works
Probiotics synergized with conventional regimen in managing Parkinson’s disease
Sun, H., Zhao, F., Liu, Y., Ma, T., Jin, H., Quan, K., Leng, B., Zhao, J., Yuan, X., Li, Z., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00327-6 · Cited by 136 · see citing works
Metta, V., Leta, V., Mrudula, K. R., Prashanth, L. K., Goyal, V., Borgohain, R., Chung-Faye, G., & Chaudhuri, K. R. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10567-w · Cited by 130 · see citing works
The Relationship Between the Gut Microbiome and Neurodegenerative Diseases
Zhu, X., Li, B., Lou, P., Dai, T., Chen, Y., Zhuge, A., Yuan, Y., & Li, L. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00730-8 · Cited by 134 · see citing works
Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
Salim, S., Ahmad, F. A., Banu, A., & Mohammad, F. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.10.013 · Cited by 120 · see citing works
Probiotics for constipation and gut microbiota in Parkinson's disease
Du, Y., Li, Y., Xu, X., Li, R., Zhang, M., Cui, Y., Zhang, L., Wei, Z. Z., Wang, S., & Tuo, H. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.08.022 · Cited by 103 · see citing works
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101 · see citing works
Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
Oroojzadeh, P., Bostanabad, S. Y., & Lotfi, H. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02053-3 · Cited by 105 · see citing works
Xiang, S., Ji, J.-L., Li, S., Cao, X.-P., Xu, W., Tan, L., & Tan, C.-C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.730036 · Cited by 89 · see citing works
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works
Zhou, X., Lu, J., Wei, K., Wei, J., Tian, P., Yue, M., Wang, Y., Hong, D., Li, F., Wang, B., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9424582 · Cited by 85 · see citing works
Materials Used for the Microencapsulation of Probiotic Bacteria in the Food Industry
Kowalska, E., Ziarno, M., Ekielski, A., & Żelaziński, T. (2022) · Molecules · doi:10.3390/molecules27103321 · Cited by 85 · see citing works
Dong, T. S., & Mayer, E. A. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.024 · Cited by 84 · see citing works
Lu, C., Chang, H., Weng, Y.-H., Chen, C.-C., Kuo, Y.-S., & Tsai, Y.-C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.650053 · Cited by 80 · see citing works
Leta, V., Chaudhuri, К. R., Milner, O., Chung‐Faye, G., Metta, V., Pariante, C. M., & Borsini, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.026 · Cited by 77 · see citing works
Li, T., Chu, C., Yu, L., Zhai, Q., Wang, S., Zhao, J., Zhang, H., Chen, W., & Tian, F. (2022) · Nutrients · doi:10.3390/nu14214678 · Cited by 76 · see citing works
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 77 · see citing works
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69 · see citing works
Role of Probiotics and Diet in the Management of Neurological Diseases and Mood States: A Review
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., & Chaiyasut, C. (2022) · Microorganisms · doi:10.3390/microorganisms10112268 · Cited by 73 · see citing works
Yang, X., He, X., Xu, S., Zhang, Y., Mo, C., Lai, Y., Song, Y., Zheng, Y., Ai, P., Qian, Y., et al. (2023) · Food & Function · doi:10.1039/d3fo00728f · Cited by 67 · see citing works
Probiotics in Extraintestinal Diseases: Current Trends and New Directions
Kiousi, D. E., Karapetsas, A., Karolidou, K., Panayiotidis, M. I., Pappa, A., & Galanis, Α. (2019) · Nutrients · doi:10.3390/nu11040788 · Cited by 80 · see citing works
Probiotics and the Treatment of Parkinson's Disease: An Update
Mirzaei, H., Sedighi, S., Kouchaki, E., Barati, E., Dadgostar, E., Aschner, M., & Tamtaji, O. R. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01128-w · Cited by 57 · see citing works
Park, J. M., Lee, S. C., Ham, C., & Kim, Y. W. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00536-1 · Cited by 59 · see citing works
The significance of uric acid in the diagnosis and treatment of Parkinson disease
Yu, Z., Zhang, S., Wang, D., Fan, M., Gao, F., Sun, W., Li, Z., & Li, S. (2017) · Medicine · doi:10.1097/md.0000000000008502 · Cited by 54 · see citing works
Wang, Y., Chen, W., Han, Y., Xu, X., Yang, A., Wei, J., Hong, D., Fang, X., & Chen, T. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10505 · Cited by 52 · see citing works
Menozzi, E., & Schapira, A. H. V. (2024) · CNS Drugs · doi:10.1007/s40263-024-01073-4 · Cited by 47 · see citing works
Skowron, K., Budzyńska, A., Wiktorczyk-Kapischke, N., Chomacka, K., Grudlewska‐Buda, K., Wilk, M., Wałecka-Zacharska, E., Andrzejewska, M., & Gospodarek-Komkowska, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147820 · Cited by 47 · see citing works
Microbial treatment: the potential application for Parkinson’s disease
Fang, X. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3641-6 · Cited by 45 · see citing works
Gut microbiome-mediated mechanisms in aging-related diseases: are probiotics ready for prime time?
Ren, J., Li, H., Zeng, G., Pang, B., Wang, Q., & Wei, J.-P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1178596 · Cited by 44 · see citing works
Pereira, T. D. M. C., Côco, L. Z., Ton, A. M. M., Meyrelles, S. S., Campos‐Toimil, M., Campagnaro, B. P., & Vasquez, E. C. (2021) · Antioxidants · doi:10.3390/antiox10111845 · Cited by 42 · see citing works
Yassin, L. K., Skrabulyte-Barbulescu, J., Alshamsi, S. H., Saeed, S., Alkuwaiti, S. H., Almazrouei, S., Alnuaimi, A., BaniYas, S., Aldhaheri, D., Alderei, M., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1667448 · Cited by 46 · see citing works
Tao, J., An, Y., Xu, L., Wang, Y., Wang, C., Li, P., Li, M., Yan, D., Wang, M., Zhong, G., et al. (2023) · Food & Function · doi:10.1039/d2fo03379h · Cited by 39 · see citing works
Coretti, L., Buommino, E., & Lembo, F. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1433747 · Cited by 39 · see citing works
Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials
Hong, C., Chen, J., & Huang, T. (2022) · Aging · doi:10.18632/aging.204266 · Cited by 38 · see citing works
Neurodegenerative Microbially-Shaped Diseases: Oxidative Stress Meets Neuroinflammation
Silva, D. F., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2022) · Antioxidants · doi:10.3390/antiox11112141 · Cited by 39 · see citing works
The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications
Menozzi, E., Schapira, A. H. V., & Borghammer, P. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70029 · Cited by 40 · see citing works
Deidda, G., & Biazzo, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753915 · Cited by 36 · see citing works
Fang, X., Liu, S., Muhammad, B., Zheng, M., Ge, X., Xu, Y., Shu, K., Zhang, Y., Yu, Y., Zheng, K., et al. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.391191 · Cited by 37 · see citing works
Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., & Chaiyasut, C. (2022) · Microorganisms · doi:10.3390/microorganisms10081544 · Cited by 36 · see citing works
Efficacy of probiotic supplements on Parkinson's disease: A systematic review and meta-analysis
Jin, X., Dong, W., Chang, K., Yan, Y., & Liu, X. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103045 · Cited by 35 · see citing works
Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
Mincic, A. M., Antal, M., Filip, L. A., & Miere, D. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.036 · Cited by 35 · see citing works
Gastrointestinal Dysfunction in Parkinson’s Disease
Safarpour, D., Sharzehi, K., & Pfeiffer, R. F. (2022) · Drugs · doi:10.1007/s40265-021-01664-1 · Cited by 36 · see citing works
Morella, I., Negro, M., Dossena, M., Brambilla, R., & D’Antona, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109718 · Cited by 35 · see citing works
Tan, L. Y., Yeo, X. Y., Bae, H., Lee, D. P. S., Ho, R., Kim, J. E., Jo, D., & Jung, S. (2021) · Life · doi:10.3390/life11070698 · Cited by 34 · see citing works
Relationship among Parkinson’s disease, constipation, microbes, and microbiological therapy
Yuan, X.-Y., Chen, Y., & Liu, Z. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i3.225 · Cited by 35 · see citing works
Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease
Chu, C., Yu, L., Li, Y. H., Guo, H., Zhai, Q., Chen, W., & Tian, F. (2023) · Food & Function · doi:10.1039/d2fo03825k · Cited by 32 · see citing works
Psychobiotics for Mitigation of Neuro‐Degenerative Diseases: Recent Advancements
Dhyani, P., Goyal, C., Dhull, S. B., Chauhan, A. K., Saharan, B. S., Harshita, Duhan, J. S., & Gökşen, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300461 · Cited by 30 · see citing works
Microbiome-based therapeutics for Parkinson's disease
Hamilton, A. M., Krout, I. N., White, A. C., & Sampson, T. R. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00462 · Cited by 31 · see citing works
Gut brain axis: an insight into microbiota role in Parkinson’s disease
Moustafa, S. A., Abdou, S. M., Dawood, A. S., Azar, J., Elmorsy, E. M., Rizk, N., & Salama, M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00808-2 · Cited by 29 · see citing works
Buty and the beast: the complex role of butyrate in Parkinson’s disease
Elford, J. D., Becht, N. N., Garssen, J., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1388401 · Cited by 27 · see citing works
Yin, S., & Zhu, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1038928 · Cited by 28 · see citing works
Mozaffari, S., Nikfar, S., Daniali, M., & Abdollahi, M. R. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1726319 · Cited by 25 · see citing works
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Pavan, S., Prabhu, A., Gorthi, S. P., Das, B., Mutreja, A., Shetty, V., Ramamurthy, T., & Ballal, M. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00977-2 · Cited by 25 · see citing works
Choi, J. G., Huh, E., Kim, N., Kim, D., & Oh, M. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217194 · Cited by 21 · see citing works
Magistrelli, L., Contaldi, E., Visciglia, A., Deusebio, G., Pane, M., & Amoruso, A. (2024) · Brain Sciences · doi:10.3390/brainsci14111147 · Cited by 24 · see citing works
Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works
Parkinson's disease: Are gut microbes involved?
Omotosho, A. O., Tajudeen, Y. A., Oladipo, H. J., Yusuff, S. I., Abdulkadir, M., Muili, A. O., Egbewande, O. M., Yusuf, R. O., Faniran, Z. O., Afolabi, A. O., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3130 · Cited by 20 · see citing works
Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Sun, X., Gu, R., & Bai, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05402-0 · Cited by 22 · see citing works
Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach
Forero-Rodríguez, L. J., Josephs‐Spaulding, J., Flor, S., Pinzón, A. M., & Kaleta, C. (2021) · Antioxidants · doi:10.3390/antiox11010071 · Cited by 22 · see citing works
Ghalandari, N., Assarzadegan, F., Mahdavi, H., Jamshidi, E., & Esmaily, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14312 · Cited by 20 · see citing works
The Role of the Gastrointestinal Microbiota in Parkinson’s Disease
Gabrielli, M., Verme, L. Z. D., Zocco, M. A., Nista, E. C., Ojetti, V., & Gasbarrini, A. (2024) · Biomolecules · doi:10.3390/biom15010026 · Cited by 19 · see citing works
Evaluating the Role of Probiotics in the Prevention and Management of Age-Related Diseases
Kiousi, D. E., Kouroutzidou, A. Z., Neanidis, K., Matthaios, D., Pappa, A., & Galanis, Α. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073628 · Cited by 19 · see citing works
When the microbiome helps the brain‐current evidence
Drljača, J., Milosevic, N. P., Milanović, M., Abenavoli, L., & Milić, N. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14076 · Cited by 18 · see citing works
Dong, Y., Qi, Y., Chen, J., Han, S., Su, W., Ma, X., Yu, Y., & Wang, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04038-2 · Cited by 18 · see citing works
The Role of an Altered Gut Microbiome in Parkinson’s Disease: A Narrative Review
Hashish, S. A., & Salama, M. (2023) · Applied Microbiology · doi:10.3390/applmicrobiol3020030 · Cited by 17 · see citing works
Cui, J., Wang, W., Tang, Y., Feng, S., Liu, H., & Hao, Z. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20240041 · Cited by 20 · see citing works
Regulation of Pain Perception by Microbiota in Parkinson Disease
Manjarres, Z., Calvo, M., & Pacheco, R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000674 · Cited by 15 · see citing works
Boziki, M. K., Grigoriadis, N., Papaefthymiou, A., Doulberis, M., Pοlyzos, S. A., Gavalas, E., Deretzi, G., Karafoulidou, E., Kesidou, E., Taloumtzis, C., et al. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104938 · Cited by 16 · see citing works
Mohiuddin, M., Asghar, T., Hameed, H., Din, A. M., Siddique, A., Younas, S., Din, M. M. U., & Ara, R. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04632-z · Cited by 13 · see citing works
Gut-directed therapy in Parkinson’s disease
Benvenuti, L., Salvo, C. D., Bellini, G., Seguella, L., Rettura, F., Esposito, G., Antonioli, L., Ceravolo, R., Bernardini, N., Pellegrini, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1407925 · Cited by 13 · see citing works
Clostridioides difficile and neurological disorders: new perspectives
Biazzo, M., Allegra, M., & Deidda, G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946601 · Cited by 11 · see citing works
Moreno, L. O., Bagüés, A., Martı́nez, V., & Abalo, R. (2023) · Nutrients · doi:10.3390/nu15122775 · Cited by 11 · see citing works
The Role of Probiotics In Tissue Engineering And Regenerative Medicine
Golchin, A., Ranjbarvan, P., Parviz, S., Shokati, A., Naderi, R., Rasmi, Y., Kiani, S., Moradi, F., Heidari, F., Saltanatpour, Z., et al. (2023) · Regenerative Medicine · doi:10.2217/rme-2022-0209 · Cited by 12 · see citing works
Merchak, A. R., Bolen, M. L., Tansey, M. G., & Menees, K. B. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00476 · Cited by 12 · see citing works
Zhu, F., Yin, S., Wang, Y., Zhong, Y., Ji, Q., & Wu, J. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s499406 · Cited by 11 · see citing works
Gut-oriented disease modifying therapy for Parkinson's disease
Lin, C., Lai, H., & Wu, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.09.010 · Cited by 11 · see citing works
Feed your microbiome and improve sleep, stress resilience, and cognition
Chichlowski, M., Cotter, J., Fawkes, N., & Pandey, N. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00097 · Cited by 10 · see citing works
Impact of Nutrition on the Gut Microbiota: Implications for Parkinson’s Disease
Sobral, J., Empadinhas, N., Esteves, A. R., & Cardoso, S. M. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuae208 · Cited by 10 · see citing works
Nutritional and dietary clinical trials for Parkinson's disease: a narrative review
Giannakis, A., Chondrogiorgi, M., Konitsiotis, S., & Sidiropoulos, C. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02901-7 · Cited by 10 · see citing works
Nutritional aspects in Parkinson’s disease
Gątarek, P., & Kałużna‐Czaplińska, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1902261 · Cited by 10 · see citing works
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
Gordon, J., Lockard, G., Monsour, M., Alayli, A., Choudhary, H., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710138 · Cited by 10 · see citing works
Prebiotics and probiotics and Parkinson's disease
Amani, R., & Mehrabani, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00034-2 · Cited by 9 · see citing works
Gut Microbiome as a Source of Probiotic Drugs for Parkinson’s Disease
Poluektova, E. U., Stavrovskaya, A. V., Pavlova, A. K., Yunes, R. А., Марсова, М. В., Koshenko, T. A., Illarioshkin, S. N., & Даниленко, В. Н. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199290 · Cited by 13 · see citing works
Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics
Hor, J. W., Toh, T. S., Lim, S., & Tan, A. H. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240172 · Cited by 9 · see citing works
Fasano, A., & Flaherty, S. (2021) · The MIT Press eBooks · doi:10.7551/mitpress/11291.001.0001 · Cited by 12 · see citing works
Prasad, A., Glover, C., Shuler, M. G. H., Dayal, V., & Lithander, F. E. (2025) · Proceedings of The Nutrition Society · doi:10.1017/s0029665125101213 · Cited by 8 · see citing works
Parkinson’s Disease in Romania: A Scoping Review
Roşca, E. C., Tudor, R., Cornea, A., & Simu, M. A. (2021) · Brain Sciences · doi:10.3390/brainsci11060709 · Cited by 8 · see citing works
Innovative Interventions: Postbiotics and Psychobiotics in Neurodegenerative Disease Treatment
Gupta, M. K., Chauhan, K., Bhardwaj, S., & Srivastava, R. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10632-0 · Cited by 9 · see citing works
Zhang, W., Jiao, Y., Wen, H., Bin, X., Xuefei, W., Lan, J., & Liuyin, Z. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1407241 · Cited by 6 · see citing works
Li, X., Hao, X., Chen, C., Zhai, C., Pan, T., Zhou, X., Liu, Y., Wu, D., & Chen, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1421270 · Cited by 5 · see citing works
Chowdhury, M., Chaudhary, N. R., Kaur, P., Goyal, A., & Sahu, S. K. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265267536231121095634 · Cited by 5 · see citing works
- Authors
- Georgescu, D., Ancusa, O., Georgescu, L., Ionita, I., & Reisz, D.
- Affiliations
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Corresponding author
- Ancusa, Oana
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2016-11
- Volume
- Volume 11
- Pages
- 1601-1608
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- PMC
- PMC5113937
- OpenAlex
- W2550869378
- Cited by
- 138
- References
- 29
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 29 · 2023: 21 · 2022: 34 · 2021: 20 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Interventions in Aging (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- Parkinson's disease, non-motor symptoms, gastrointestinal symptoms, constipation, abdominal pain, bloating, trimebutine, probiotics, Lactobacillus acidophilus, Bifidobacterium infantis, dietary fiber, older adults, levodopa, dopamine agonists, symptom management, quality of life, activities of daily living
- MeSH terms
- Age Factors, Aged, Bifidobacterium, Female, Gastrointestinal Agents, Gastrointestinal Diseases, Humans, Lactobacillus acidophilus, Male, Parkinson Disease, Trimebutine, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
